• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GH

GH

Guardant Health, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD127.03

-3.14 (-2.41%)

Rating:C+

Company Profile

CEO

Helmy Eltoukhy

IPO Date

2018-10-04

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$129.83

Prev. Close

$130.17

Day Low

$125.50

Day High

$129.87

52W Low

$40.35

52W High

$133.97

Market Cap

$16.84B

Volume

2.06M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.2%

Avg Negative

15.3%

Avg Neutral

35.4%

News Feed

Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic

Business Wire·7/20/2021·↑ positive

AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round

PRNewsWire·7/19/2021·↑ positive

Guardant Health to Report Second Quarter Financial Results on August 5, 2021

Business Wire·7/13/2021·↑ positive

Guardant Health Expands Guardant360® Portfolio With New Tests for Treatment Response Monitoring and Complete Genomic Profiling

Business Wire·6/22/2021·↑ positive

CORRECTING and REPLACING Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers

Business Wire·6/18/2021·↑ positive

Guardant Health: A Stalwart With 20% Upside

Seeking Alpha·6/7/2021·↑ positive

Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Blood Test Highly Accurate in Detecting Colorectal Cancer in Patients With Early-Stage Cancer

Business Wire·6/4/2021·↑ positive

Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen's LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer

Business Wire·5/28/2021·↑ positive

Guardant Health Files Lawsuit Against Natera for Misleading Oncologists

Business Wire·5/28/2021·↓ negative

Where Guardant Health Stands With Analysts

Benzinga·5/25/2021·↓ negative